Clinical trials: Tuberculosis in Solid Organ Transplant Recipients
Monitoring, Immunologic, Active Tuberculosis
New Generation IGRA in Immunocompromised Individuals
Evaluation of a new ELISA based interferon-gamma release assay (QuantiFERON TB plus In-tube test) in immunocompromized patients
- Conditions
- Monitoring, Immunologic, Active Tuberculosis, Tuberculosis in Solid Organ Transplant Recipients, Tuberculosis in Marrow Transplant Recipients
- Trial name
- TBnet#54 (NCT02639936)
- Where
- 16 sites in Denmark, Germany and 8 more
- Volunteers
- 2,663 people, healthy volunteers welcome
- Sponsor
- Tuberculosis Network European Trialsgroup
Latent Tuberculosis Infection, Infection in Solid Organ Transplant Recipients
"Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients".
A multicenter, prospective, non-inferiority, randomized and open clinical trial comparing levofloxacin with isoniazid in the treatment of latent tuberculosis infection in patients eligible for liver transplantation.
- Trial name
- FLISH-ILT (NCT01761201)
- Testing
- Levofloxacin, Isoniazid
- Where
- 18 sites in Spain
- Volunteers
- 68 people
- Sponsor
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla